{"entity":{"type":"insider","cik":"0001551966","url":"/insider/0001551966","json_url":"/insider/0001551966.json","name":"Hopfner Robert Lorne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":17,"first":"2020-06-16","last":"2025-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Hopfner Robert Lorne","source":"filing","n_filings":17,"first_seen":"2020-06-16","last_seen":"2025-12-22"}],"transactions":[{"id":4314498,"accession":"0001012975-25-000937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-25-000937","line_url":"/filing/0001012975-25-000937#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Evommune, Inc.","issuer_ticker":"EVMN","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":17.35,"price_display":"17.35","price_state":"stated","total_value":17350.0,"total_display":"17,350.00","shares_owned_after":4026.0,"shares_owned_after_display":"4,026","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-22","scope":"insider"},{"id":8670871,"accession":"0000950170-23-038268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-038268","line_url":"/filing/0000950170-23-038268#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714285.0,"shares_display":"714,285","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":3428568.0,"total_display":"3,428,568.00","shares_owned_after":1571741.0,"shares_owned_after_display":"1,571,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8670867,"accession":"0000950170-23-038268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-038268","line_url":"/filing/0000950170-23-038268#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":119048.0,"shares_display":"119,048","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":571430.4,"total_display":"571,430.40","shares_owned_after":2923110.0,"shares_owned_after_display":"2,923,110","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8723632,"accession":"0001209191-23-029521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029521","line_url":"/filing/0001209191-23-029521#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":228702.0,"shares_display":"228,702","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":1429387.5,"total_display":"1,429,387.50","shares_owned_after":3661518.0,"shares_owned_after_display":"3,661,518","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-15","scope":"insider"},{"id":8723630,"accession":"0001209191-23-029521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029521","line_url":"/filing/0001209191-23-029521#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":219230.0,"shares_display":"219,230","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":1420610.4,"total_display":"1,420,610.40","shares_owned_after":3432816.0,"shares_owned_after_display":"3,432,816","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider"},{"id":8019584,"accession":"0001209191-23-021647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021647","line_url":"/filing/0001209191-23-021647#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":344592.0,"shares_display":"344,592","price_per_share":4.5379,"price_display":"4.54","price_state":"stated","total_value":1563724.0368,"total_display":"1,563,724.04","shares_owned_after":3213586.0,"shares_owned_after_display":"3,213,586","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-30","scope":"insider"},{"id":8679082,"accession":"0001209191-23-021559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-021559","line_url":"/filing/0001209191-23-021559#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":156766.0,"shares_display":"156,766","price_per_share":4.1612,"price_display":"4.16","price_state":"stated","total_value":652334.6792,"total_display":"652,334.68","shares_owned_after":2868994.0,"shares_owned_after_display":"2,868,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-29","scope":"insider"},{"id":8679079,"accession":"0001209191-23-021559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021559","line_url":"/filing/0001209191-23-021559#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51074.0,"shares_display":"51,074","price_per_share":3.6952,"price_display":"3.70","price_state":"stated","total_value":188728.6448,"total_display":"188,728.64","shares_owned_after":2712228.0,"shares_owned_after_display":"2,712,228","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":6751937,"accession":"0001209191-22-024919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024919","line_url":"/filing/0001209191-22-024919#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1070000.0,"shares_display":"1,070,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":3948300.0,"total_display":"3,948,300.00","shares_owned_after":2661154.0,"shares_owned_after_display":"2,661,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":4451348,"accession":"0000899243-21-031635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-031635","line_url":"/filing/0000899243-21-031635#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Rallybio Corp","issuer_ticker":"RLYB","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":576923.0,"shares_display":"576,923","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":7499999.0,"total_display":"7,499,999.00","shares_owned_after":2267411.0,"shares_owned_after_display":"2,267,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":5434601,"accession":"0001062993-21-001201","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-9","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37271.0,"shares_display":"37,271","price_per_share":25.75,"price_display":"25.75","price_state":"stated","total_value":959728.25,"total_display":"959,728.25","shares_owned_after":1446305.0,"shares_owned_after_display":"1,446,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":5434598,"accession":"0001062993-21-001201","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-8","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26688.0,"shares_display":"26,688","price_per_share":26.78,"price_display":"26.78","price_state":"stated","total_value":714704.64,"total_display":"714,704.64","shares_owned_after":1419617.0,"shares_owned_after_display":"1,419,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":5434595,"accession":"0001062993-21-001201","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-7","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7567.0,"shares_display":"7,567","price_per_share":27.64,"price_display":"27.64","price_state":"stated","total_value":209151.88,"total_display":"209,151.88","shares_owned_after":1412050.0,"shares_owned_after_display":"1,412,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":5434592,"accession":"0001062993-21-001201","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-6","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6632.0,"shares_display":"6,632","price_per_share":28.66,"price_display":"28.66","price_state":"stated","total_value":190073.12,"total_display":"190,073.12","shares_owned_after":1405418.0,"shares_owned_after_display":"1,405,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":5434590,"accession":"0001062993-21-001201","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-5","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93740.0,"shares_display":"93,740","price_per_share":28.75,"price_display":"28.75","price_state":"stated","total_value":2695025.0,"total_display":"2,695,025.00","shares_owned_after":1483576.0,"shares_owned_after_display":"1,483,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":5434587,"accession":"0001062993-21-001201","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-4","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88756.0,"shares_display":"88,756","price_per_share":28.07,"price_display":"28.07","price_state":"stated","total_value":2491380.92,"total_display":"2,491,380.92","shares_owned_after":1577316.0,"shares_owned_after_display":"1,577,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":5434584,"accession":"0001062993-21-001201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38248.0,"shares_display":"38,248","price_per_share":27.12,"price_display":"27.12","price_state":"stated","total_value":1037285.76,"total_display":"1,037,285.76","shares_owned_after":1666072.0,"shares_owned_after_display":"1,666,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":5434581,"accession":"0001062993-21-001201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50874.0,"shares_display":"50,874","price_per_share":25.64,"price_display":"25.64","price_state":"stated","total_value":1304409.36,"total_display":"1,304,409.36","shares_owned_after":1733242.0,"shares_owned_after_display":"1,733,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5434577,"accession":"0001062993-21-001201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-001201","line_url":"/filing/0001062993-21-001201#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28922.0,"shares_display":"28,922","price_per_share":26.06,"price_display":"26.06","price_state":"stated","total_value":753707.32,"total_display":"753,707.32","shares_owned_after":1704320.0,"shares_owned_after_display":"1,704,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5042193,"accession":"0001062993-21-000894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000894","line_url":"/filing/0001062993-21-000894#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2768.0,"shares_display":"2,768","price_per_share":25.06,"price_display":"25.06","price_state":"stated","total_value":69366.08,"total_display":"69,366.08","shares_owned_after":1784116.0,"shares_owned_after_display":"1,784,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":5042190,"accession":"0001062993-21-000894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000894","line_url":"/filing/0001062993-21-000894#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14234.0,"shares_display":"14,234","price_per_share":25.13,"price_display":"25.13","price_state":"stated","total_value":357700.42,"total_display":"357,700.42","shares_owned_after":1786884.0,"shares_owned_after_display":"1,786,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":4513406,"accession":"0001062993-21-000781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000781","line_url":"/filing/0001062993-21-000781#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":50140.0,"total_display":"50,140.00","shares_owned_after":1801118.0,"shares_owned_after_display":"1,801,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-28","filed_date":"2021-02-02","scope":"insider"},{"id":4718514,"accession":"0001062993-21-000662","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-000662","line_url":"/filing/0001062993-21-000662#line-5","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2140.0,"shares_display":"2,140","price_per_share":25.3,"price_display":"25.30","price_state":"stated","total_value":54142.0,"total_display":"54,142.00","shares_owned_after":1803118.0,"shares_owned_after_display":"1,803,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-27","scope":"insider"},{"id":4718507,"accession":"0001062993-21-000662","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-000662","line_url":"/filing/0001062993-21-000662#line-4","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16769.0,"shares_display":"16,769","price_per_share":25.23,"price_display":"25.23","price_state":"stated","total_value":423081.87,"total_display":"423,081.87","shares_owned_after":1806631.0,"shares_owned_after_display":"1,806,631","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider"},{"id":4718502,"accession":"0001062993-21-000662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-000662","line_url":"/filing/0001062993-21-000662#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1373.0,"shares_display":"1,373","price_per_share":26.13,"price_display":"26.13","price_state":"stated","total_value":35876.49,"total_display":"35,876.49","shares_owned_after":1805258.0,"shares_owned_after_display":"1,805,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider"},{"id":4718499,"accession":"0001062993-21-000662","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000662","line_url":"/filing/0001062993-21-000662#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19511.0,"shares_display":"19,511","price_per_share":25.61,"price_display":"25.61","price_state":"stated","total_value":499676.71,"total_display":"499,676.71","shares_owned_after":1838861.0,"shares_owned_after_display":"1,838,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":4718494,"accession":"0001062993-21-000662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000662","line_url":"/filing/0001062993-21-000662#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15461.0,"shares_display":"15,461","price_per_share":26.07,"price_display":"26.07","price_state":"stated","total_value":403068.27,"total_display":"403,068.27","shares_owned_after":1823400.0,"shares_owned_after_display":"1,823,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":4718481,"accession":"0001062993-21-000557","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-000557","line_url":"/filing/0001062993-21-000557#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11383.0,"shares_display":"11,383","price_per_share":25.16,"price_display":"25.16","price_state":"stated","total_value":286396.28,"total_display":"286,396.28","shares_owned_after":1858372.0,"shares_owned_after_display":"1,858,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-22","scope":"insider"},{"id":4718477,"accession":"0001062993-21-000557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000557","line_url":"/filing/0001062993-21-000557#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":25.11,"price_display":"25.11","price_state":"stated","total_value":2511.0,"total_display":"2,511.00","shares_owned_after":1869755.0,"shares_owned_after_display":"1,869,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-22","scope":"insider"},{"id":4718475,"accession":"0001062993-21-000557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000557","line_url":"/filing/0001062993-21-000557#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19046.0,"shares_display":"19,046","price_per_share":25.35,"price_display":"25.35","price_state":"stated","total_value":482816.1,"total_display":"482,816.10","shares_owned_after":1869855.0,"shares_owned_after_display":"1,869,855","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider"},{"id":5397540,"accession":"0001062993-21-000448","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-000448","line_url":"/filing/0001062993-21-000448#line-5","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42516.0,"shares_display":"42,516","price_per_share":25.55,"price_display":"25.55","price_state":"stated","total_value":1086283.8,"total_display":"1,086,283.80","shares_owned_after":1895901.0,"shares_owned_after_display":"1,895,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider"},{"id":5397537,"accession":"0001062993-21-000448","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-000448","line_url":"/filing/0001062993-21-000448#line-4","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":26.05,"price_display":"26.05","price_state":"stated","total_value":182350.0,"total_display":"182,350.00","shares_owned_after":1888901.0,"shares_owned_after_display":"1,888,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider"},{"id":5397535,"accession":"0001062993-21-000448","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-000448","line_url":"/filing/0001062993-21-000448#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22869.0,"shares_display":"22,869","price_per_share":25.74,"price_display":"25.74","price_state":"stated","total_value":588648.06,"total_display":"588,648.06","shares_owned_after":1942225.0,"shares_owned_after_display":"1,942,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":5397528,"accession":"0001062993-21-000448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000448","line_url":"/filing/0001062993-21-000448#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3808.0,"shares_display":"3,808","price_per_share":26.05,"price_display":"26.05","price_state":"stated","total_value":99198.4,"total_display":"99,198.40","shares_owned_after":1938417.0,"shares_owned_after_display":"1,938,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":5397525,"accession":"0001062993-21-000448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000448","line_url":"/filing/0001062993-21-000448#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14918.0,"shares_display":"14,918","price_per_share":25.88,"price_display":"25.88","price_state":"stated","total_value":386077.84,"total_display":"386,077.84","shares_owned_after":1965094.0,"shares_owned_after_display":"1,965,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-19","scope":"insider"},{"id":4363936,"accession":"0001062993-21-000354","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-7","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26010.0,"shares_display":"26,010","price_per_share":25.9,"price_display":"25.90","price_state":"stated","total_value":673659.0,"total_display":"673,659.00","shares_owned_after":1983112.0,"shares_owned_after_display":"1,983,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-13","scope":"insider"},{"id":4363931,"accession":"0001062993-21-000354","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-6","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":26.34,"price_display":"26.34","price_state":"stated","total_value":81654.0,"total_display":"81,654.00","shares_owned_after":1980012.0,"shares_owned_after_display":"1,980,012","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-13","scope":"insider"},{"id":4363926,"accession":"0001062993-21-000354","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-5","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17666.0,"shares_display":"17,666","price_per_share":26.35,"price_display":"26.35","price_state":"stated","total_value":465499.1,"total_display":"465,499.10","shares_owned_after":2010023.0,"shares_owned_after_display":"2,010,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":4363922,"accession":"0001062993-21-000354","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-4","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":901.0,"shares_display":"901","price_per_share":27.05,"price_display":"27.05","price_state":"stated","total_value":24372.05,"total_display":"24,372.05","shares_owned_after":2009122.0,"shares_owned_after_display":"2,009,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":4363918,"accession":"0001062993-21-000354","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24980.0,"shares_display":"24,980","price_per_share":26.69,"price_display":"26.69","price_state":"stated","total_value":666716.2,"total_display":"666,716.20","shares_owned_after":2039895.0,"shares_owned_after_display":"2,039,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":4363915,"accession":"0001062993-21-000354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12480.0,"shares_display":"12,480","price_per_share":25.42,"price_display":"25.42","price_state":"stated","total_value":317241.6,"total_display":"317,241.60","shares_owned_after":2064875.0,"shares_owned_after_display":"2,064,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":4363910,"accession":"0001062993-21-000354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000354","line_url":"/filing/0001062993-21-000354#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12206.0,"shares_display":"12,206","price_per_share":27.02,"price_display":"27.02","price_state":"stated","total_value":329806.12,"total_display":"329,806.12","shares_owned_after":2027689.0,"shares_owned_after_display":"2,027,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":4608149,"accession":"0001062993-21-000219","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-8","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31468.0,"shares_display":"31,468","price_per_share":26.43,"price_display":"26.43","price_state":"stated","total_value":831699.24,"total_display":"831,699.24","shares_owned_after":2086499.0,"shares_owned_after_display":"2,086,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-08","scope":"insider"},{"id":4608145,"accession":"0001062993-21-000219","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-7","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8944.0,"shares_display":"8,944","price_per_share":27.08,"price_display":"27.08","price_state":"stated","total_value":242203.52,"total_display":"242,203.52","shares_owned_after":2077555.0,"shares_owned_after_display":"2,077,555","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-08","scope":"insider"},{"id":4608140,"accession":"0001062993-21-000219","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-6","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":28.23,"price_display":"28.23","price_state":"stated","total_value":5646.0,"total_display":"5,646.00","shares_owned_after":2077355.0,"shares_owned_after_display":"2,077,355","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-08","scope":"insider"},{"id":4608137,"accession":"0001062993-21-000219","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-5","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24524.0,"shares_display":"24,524","price_per_share":27.75,"price_display":"27.75","price_state":"stated","total_value":680541.0,"total_display":"680,541.00","shares_owned_after":2141023.0,"shares_owned_after_display":"2,141,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"},{"id":4608134,"accession":"0001062993-21-000219","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-4","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22587.0,"shares_display":"22,587","price_per_share":28.8,"price_display":"28.80","price_state":"stated","total_value":650505.6,"total_display":"650,505.60","shares_owned_after":2118436.0,"shares_owned_after_display":"2,118,436","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"},{"id":4608128,"accession":"0001062993-21-000219","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-3","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":469.0,"shares_display":"469","price_per_share":29.51,"price_display":"29.51","price_state":"stated","total_value":13840.19,"total_display":"13,840.19","shares_owned_after":2117967.0,"shares_owned_after_display":"2,117,967","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"},{"id":4608124,"accession":"0001062993-21-000219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-2","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34913.0,"shares_display":"34,913","price_per_share":29.24,"price_display":"29.24","price_state":"stated","total_value":1020856.12,"total_display":"1,020,856.12","shares_owned_after":2188054.0,"shares_owned_after_display":"2,188,054","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider"},{"id":4608120,"accession":"0001062993-21-000219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-000219","line_url":"/filing/0001062993-21-000219#line-1","is_derivative":false,"issuer_cik":"0001551966","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001551966","owner_cik":"0001551966","owner_name":"Hopfner Robert Lorne","owner_url":"/insider/0001551966","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22507.0,"shares_display":"22,507","price_per_share":29.99,"price_display":"29.99","price_state":"stated","total_value":674984.93,"total_display":"674,984.93","shares_owned_after":2165547.0,"shares_owned_after_display":"2,165,547","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider"}],"next_cursor":"2021-01-06|4608120","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002044725","name":"Evommune, Inc.","url":"/issuer/0002044725","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2025-12-22","last_seen":"2025-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2020-07-28","last_seen":"2023-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001739410","name":"Rallybio Corp","url":"/issuer/0001739410","role":"Director","n_filings":1,"first_seen":"2021-08-04","last_seen":"2021-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Director","n_filings":9,"first_seen":"2020-06-16","last_seen":"2021-02-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551966","retrieved_at":"2026-08-21T23:49:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}